RPRX(Royalty Pharma plc) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-17 | Coyne Terrance P. | EVP & CFO | 公开市场卖出 | 9,835 | $68.30 |
| 2026-11-17 | Coyne Terrance P. | EVP & CFO | 公开市场卖出 | 14,751 | $68.30 |
| 2026-11-17 | Hite Christopher | EVP & Chairman, Partnering | 公开市场卖出 | 100,000 | $68.15 |
| 2026-11-16 | Urist Marshall | EVP, Research & Investments | 公开市场卖出 | 1,408 | $69.99 |
| 2026-11-16 | Urist Marshall | EVP, Research & Investments | 公开市场卖出 | 23,592 | $69.47 |
| 2026-11-16 | Coyne Terrance P. | EVP & CFO | 公开市场卖出 | 7,122 | $68.87 |
| 2026-11-16 | Coyne Terrance P. | EVP & CFO | 公开市场卖出 | 90,165 | $68.87 |
| 2026-11-16 | Coyne Terrance P. | EVP & CFO | 公开市场卖出 | 135,249 | $68.87 |
| 2026-10-05 | Urist Marshall | EVP, Research & Investments | 公开市场卖出 | 4,126 | $57.10 |
| 2026-09-28 | Urist Marshall | EVP, Research & Investments | 公开市场卖出 | 4,126 | $57.88 |
| 2026-09-22 | Hite Christopher | EVP & Chairman, Partnering | 公开市场卖出 | 3,927 | $58.93 |
| 2026-09-22 | Hite Christopher | EVP & Chairman, Partnering | 公开市场卖出 | 96,073 | $58.51 |
| 2026-08-18 | Hite Christopher | EVP & Chairman, Partnering | 公开市场卖出 | 100,000 | $59.97 |
| 2026-08-13 | Coyne Terrance P. | EVP & CFO | 公开市场卖出 | 1,772 | $59.14 |
| 2026-08-13 | Coyne Terrance P. | EVP & CFO | 公开市场卖出 | 9,230 | $58.59 |
| 2026-07-01 | Urist Marshall | EVP, Research & Investments | 公开市场卖出 | 9,099 | $55.88 |
| 2026-06-30 | Hite Christopher | EVP & Chairman, Partnering | 公开市场卖出 | 600 | $57.09 |
| 2026-06-30 | Hite Christopher | EVP & Chairman, Partnering | 公开市场卖出 | 29,400 | $56.44 |
| 2026-06-30 | Hite Christopher | EVP & Chairman, Partnering | 公开市场卖出 | 2,554 | $57.10 |
| 2026-06-30 | Hite Christopher | EVP & Chairman, Partnering | 公开市场卖出 | 97,446 | $56.50 |